These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 15129698)
1. Comparison of methodologies for the in vivo assessment of 18FLT utilisation in colorectal cancer. Visvikis D; Francis D; Mulligan R; Costa DC; Croasdale I; Luthra SK; Taylor I; Ell PJ Eur J Nucl Med Mol Imaging; 2004 Feb; 31(2):169-78. PubMed ID: 15129698 [TBL] [Abstract][Full Text] [Related]
2. Kinetic analysis of 3'-deoxy-3'-fluorothymidine PET studies: validation studies in patients with lung cancer. Muzi M; Vesselle H; Grierson JR; Mankoff DA; Schmidt RA; Peterson L; Wells JM; Krohn KA J Nucl Med; 2005 Feb; 46(2):274-82. PubMed ID: 15695787 [TBL] [Abstract][Full Text] [Related]
3. Parametric Net Influx Rate Images of Ilan E; Sandström M; Velikyan I; Sundin A; Eriksson B; Lubberink M J Nucl Med; 2017 May; 58(5):744-749. PubMed ID: 27789716 [No Abstract] [Full Text] [Related]
4. Kinetic modeling of 3'-deoxy-3'-18F-fluorothymidine for quantitative cell proliferation imaging in subcutaneous tumor models in mice. Kim SJ; Lee JS; Im KC; Kim SY; Park SA; Lee SJ; Oh SJ; Lee DS; Moon DH J Nucl Med; 2008 Dec; 49(12):2057-66. PubMed ID: 18997037 [TBL] [Abstract][Full Text] [Related]
5. Potential impact of [18F]3'-deoxy-3'-fluorothymidine versus [18F]fluoro-2-deoxy-D-glucose in positron emission tomography for colorectal cancer. Francis DL; Visvikis D; Costa DC; Arulampalam TH; Townsend C; Luthra SK; Taylor I; Ell PJ Eur J Nucl Med Mol Imaging; 2003 Jul; 30(7):988-94. PubMed ID: 12739071 [TBL] [Abstract][Full Text] [Related]
6. A simplified analysis of [18F]3'-deoxy-3'-fluorothymidine metabolism and retention. Shields AF; Briston DA; Chandupatla S; Douglas KA; Lawhorn-Crews J; Collins JM; Mangner TJ; Heilbrun LK; Muzik O Eur J Nucl Med Mol Imaging; 2005 Nov; 32(11):1269-75. PubMed ID: 15991018 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of neuroendocrine liver metastases: a comparison of dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography. Armbruster M; Sourbron S; Haug A; Zech CJ; Ingrisch M; Auernhammer CJ; Nikolaou K; Paprottka PM; Rist C; Reiser MF; Sommer WH Invest Radiol; 2014 Jan; 49(1):7-14. PubMed ID: 24002080 [TBL] [Abstract][Full Text] [Related]
15. Imaging of proliferation in hepatocellular carcinoma with the in vivo marker 18F-fluorothymidine. Eckel F; Herrmann K; Schmidt S; Hillerer C; Wieder HA; Krause BJ; Schuster T; Langer R; Wester HJ; Schmid RM; Schwaiger M; Buck AK J Nucl Med; 2009 Sep; 50(9):1441-7. PubMed ID: 19690030 [TBL] [Abstract][Full Text] [Related]
16. Quantification of 18F-fluorocholine kinetics in patients with prostate cancer. Verwer EE; Oprea-Lager DE; van den Eertwegh AJ; van Moorselaar RJ; Windhorst AD; Schwarte LA; Hendrikse NH; Schuit RC; Hoekstra OS; Lammertsma AA; Boellaard R J Nucl Med; 2015 Mar; 56(3):365-71. PubMed ID: 25678491 [TBL] [Abstract][Full Text] [Related]
17. Measurement of input functions in rodents: challenges and solutions. Laforest R; Sharp TL; Engelbach JA; Fettig NM; Herrero P; Kim J; Lewis JS; Rowland DJ; Tai YC; Welch MJ Nucl Med Biol; 2005 Oct; 32(7):679-85. PubMed ID: 16243642 [TBL] [Abstract][Full Text] [Related]
18. Biokinetics of (99m)Tc-UBI 29-41 in humans. Meléndez-Alafort L; Rodríguez-Cortés J; Ferro-Flores G; Arteaga De Murphy C; Herrera-Rodríguez R; Mitsoura E; Martínez-Duncker C Nucl Med Biol; 2004 Apr; 31(3):373-9. PubMed ID: 15028250 [TBL] [Abstract][Full Text] [Related]
19. Comparison of different quantitative approaches to 18F-fluoride PET scans. Brenner W; Vernon C; Muzi M; Mankoff DA; Link JM; Conrad EU; Eary JF J Nucl Med; 2004 Sep; 45(9):1493-500. PubMed ID: 15347716 [TBL] [Abstract][Full Text] [Related]